Royalties | NAVB Message Board Posts

Navidea Biopharmaceuticals, Inc.

  NAVB website

NAVB   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  32914 of 33103  at  9/27/2020 11:04:12 AM  by

z3peru


 In response to msg 32912 by  LotBMan
view thread

Re: Royalties

 LotB, your post made me go deep into Google results on the cost of LymphoSeek.  It's interesting that there is a MOUNTAIN of technical detail on LymphoSeek, but I could not find info on the price. Except for a British publication in 2017 that stated one dose of LymphoSeek cost 1,175 pounds. That translates into $1586 in 2017.  That strikes me as high.
 
I do think you have a point that the hospital or imaging clinic will buy tilmanocept and mark it up. The reconstitution procedures to turn the LymphoSeek kit into an injectable radionuclide are mind-boggling. Thus if Jubilant sells tilmanocept for $500, the patient and his insurance company will pay $600? $700? $800?
 
But for our purposes, NAVB and Jubilant will split $500.  Why $500?  That is a real number that I have read somewhere but I am not able to reference it.  The price is related to the price of Lymphoseek.  Jed Latkin mentioned in some presentation that the actual dose required for an RA scan is greater than the dose used in a SLN scan in breast cancer, implying the price of tilmanocept for RA would be higher.
 
I do think it is strange that with all the info on the Internet, the price of LymphoSeek is simply not there.  Why such a secret? 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 312
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
32918 Re: Royalties edit at end FIRAC 14 9/27/2020 3:07:26 PM






Financial Market Data provided by
.
Loading...